Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.

A study found that waist size is a better cancer risk predictor for men compared to BMI, with an extra 4 inches increasing risk by 25 per cent. If you are a man, your waist size could be a better ...